Literature DB >> 11546697

Meningitis in infancy in England and Wales: follow up at age 5 years.

H Bedford1, J de Louvois, S Halket, C Peckham, R Hurley, D Harvey.   

Abstract

OBJECTIVE: To describe important sequelae occurring among a cohort of children aged 5 years who had had meningitis during the first year of life and who had been identified by a prospective national study of meningitis in infancy in England and Wales between 1985 and 1987.
DESIGN: Follow up questionnaires asking about the children's health and development were sent to general practitioners and parents of the children and to parents of matched controls. The organism that caused the infection and age at infection were also recorded.
SETTING: England and Wales. PARTICIPANTS: General practitioners and parents of children who had had meningitis before the age of 1 year and of matched controls. MAIN OUTCOME MEASURES: The prevalence of health and developmental problems and overall disability among children who had had meningitis compared with controls.
RESULTS: Altogether, 1584 of 1717 (92.2%) children who had had meningitis and 1391 of 1485 (93.6%) controls were successfully followed up. Among children who survived to age 5 years 247 of 1584 (15.6%) had a disability; there was a 10-fold increase in the risk of severe or moderate disability at 5 years of age among children who had had meningitis (relative risk 10.3, 95% confidence interval 6.7 to 16.0, P<0.001). There was considerable variation in the rates of severe or moderate disability in children infected with different organisms.
CONCLUSION: The long term consequences of having meningitis during the first year of life are significant: 32 of 1717 (1.8%) children died within five years. Not only did almost a fifth of children with meningitis have a permanent, severe or moderately severe disability, but subtle deficits were also more prevalent.

Entities:  

Mesh:

Year:  2001        PMID: 11546697      PMCID: PMC48156          DOI: 10.1136/bmj.323.7312.533

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

1.  Infantile meningitis in England and Wales: a two year study.

Authors:  J de Louvois; J Blackbourn; R Hurley; D Harvey
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

2.  Academic achievement in children ten to 12 years after Haemophilus influenzae meningitis.

Authors:  H M Feldman; R H Michaels
Journal:  Pediatrics       Date:  1988-03       Impact factor: 7.124

3.  Neonatal meningitis in England and Wales: 10 years on.

Authors:  D E Holt; S Halket; J de Louvois; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

4.  Managing meningitis in children: audit of notifications, rifampicin chemoprophylaxis, and audiological referrals.

Authors:  M D Shields; D Adams; P Beresford; J A Dodge
Journal:  Qual Health Care       Date:  1995-12

5.  Ataxia and deafness in children due to bacterial meningitis.

Authors:  S L Kaplan; J Goddard; M Van Kleeck; F I Catlin; R D Feigin
Journal:  Pediatrics       Date:  1981-07       Impact factor: 7.124

6.  Outcomes of bacterial meningitis in children: a meta-analysis.

Authors:  L J Baraff; S I Lee; D L Schriger
Journal:  Pediatr Infect Dis J       Date:  1993-05       Impact factor: 2.129

7.  Bacterial meningitis and sensorineural hearing loss: a prospective investigation.

Authors:  S J Berlow; D D Caldarelli; G J Matz; D H Meyer; G G Harsch
Journal:  Laryngoscope       Date:  1980-09       Impact factor: 3.325

8.  Hearing loss as a sequela of meningitis.

Authors:  J B Nadol
Journal:  Laryngoscope       Date:  1978-05       Impact factor: 3.325

9.  Adverse outcomes of bacterial meningitis in school-age survivors.

Authors:  K Grimwood; V A Anderson; L Bond; C Catroppa; R L Hore; E H Keir; T Nolan; D M Roberton
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124

10.  Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis.

Authors:  P R Dodge; H Davis; R D Feigin; S J Holmes; S L Kaplan; D P Jubelirer; B W Stechenberg; S K Hirsh
Journal:  N Engl J Med       Date:  1984-10-04       Impact factor: 91.245

View more
  69 in total

1.  Long term outcome of neonatal meningitis.

Authors:  J P Stevens; M Eames; A Kent; S Halket; D Holt; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

Review 2.  Bacterial meningitis: diagnosis and treatment.

Authors:  Russell D Snyder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

3.  Academic and behavioral limitations and health-related quality of life in school-age survivors of bacterial meningitis.

Authors:  Irene Koomen; Hein Raat; Aag Jennekens-Schinkel; Diederick E Grobbee; John J Roord; Marceline van Furth
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

4.  Incidence and outcome of pneumococcal meningitis in northern England.

Authors:  N C Weightman; J Sajith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

5.  Effect of meningitis in infancy on school-leaving examination results.

Authors:  John de Louvois; Sue Halket; David Harvey
Journal:  Arch Dis Child       Date:  2007-03-22       Impact factor: 3.791

Review 6.  Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.

Authors:  J Rodriguez-Granger; J C Alvargonzalez; A Berardi; R Berner; M Kunze; M Hufnagel; P Melin; A Decheva; G Orefici; C Poyart; J Telford; A Efstratiou; M Killian; P Krizova; L Baldassarri; B Spellerberg; A Puertas; M Rosa-Fraile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

7.  Restoration of Akt activity by the bisperoxovanadium compound bpV(pic) attenuates hippocampal apoptosis in experimental neonatal pneumococcal meningitis.

Authors:  Matthias D Sury; Lorianne Vorlet-Fawer; Claudia Agarinis; Shida Yousefi; Denis Grandgirard; Stephen L Leib; Stephan Christen
Journal:  Neurobiol Dis       Date:  2010-09-25       Impact factor: 5.996

8.  Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.

Authors:  Damian N Meli; Roney S Coimbra; Dominik G Erhart; Gerard Loquet; Caroline L Bellac; Martin G Täuber; Ulf Neumann; Stephen L Leib
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 9.  Neonatal infections: group B streptococcus.

Authors:  Paul T Heath; Luke Anthony Jardine
Journal:  BMJ Clin Evid       Date:  2014-02-28

10.  Edaravone attenuates hippocampal damage in an infant mouse model of pneumococcal meningitis by reducing HMGB1 and iNOS expression via the Nrf2/HO-1 pathway.

Authors:  Zheng Li; Qian-Qian Ma; Yan Yan; Feng-Dan Xu; Xiao-Ying Zhang; Wei-Qin Zhou; Zhi-Chun Feng
Journal:  Acta Pharmacol Sin       Date:  2016-08-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.